InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by MacBeath Gavin, Directeur Scientifique. Insider active across 1 companies, notably TScan Therapeutics, Inc.. Aggregated, 2 disclosures have been published. Total volume traded: €52k. The latest transaction was disclosed on 20 September 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€26,2094,943 shares@ €5.30230.040% mcap100.0% of flow
Voting Common Stock
SEC:0000899243-21-037147·
Ideal exit: 17 Jun 2022 (T+270)
€26,2094,943 shares@ €5.30230.040% mcap50.0% of flow
Voting Common Stock
SEC:0000899243-21-037147:0·
Ideal exit: 17 Jun 2022 (T+270)
2 of 2 declarations
About MacBeath Gavin
Gavin MacBeath is the Chief Scientific Officer of TScan Therapeutics, Inc. In this role, he is responsible for leading the company's research and development initiatives. With a strong scientific background, he plays a key role in innovation and the development of new therapies. His expertise is essential in ensuring that TScan's products meet the highest standards of safety and efficacy.
